The effect of ursodeoxycholic acid in cystic cholangiopathies

The effect of ursodeoxycholic acid in cystic cholangiopathies

Bibliographic Details
Main Authors:	Frank Lammert, Nahum Méndez-Sánchez
Format:	Article
Language:	English
Published:	Elsevier 2016-11-01
Series:	Annals of Hepatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268119311275

Similar Items

Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic AcidSummary
by: Jan Freark de Boer, et al.
Published: (2021-01-01)

Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis
by: Vincent Zimmer, et al.
Published: (2017-02-01)

Pleiotropic effects of ursodeoxycholic acid
by: Yu.М. Stepanov, et al.
Published: (2021-06-01)

IgG4 Cholangiopathy
by: Yoh Zen, et al.
Published: (2012-01-01)

Tutorial Review for Understanding of Cholangiopathy
by: Yasuni Nakanuma
Published: (2012-01-01)

Portal cholangiopathy: case report
by: Maria Cecilia Almeida Maia, et al.
Published: (2014-01-01)

Cholangiopathy: Genetics, Mechanism, and Pathology
by: Yasuni Nakanuma, et al.
Published: (2012-01-01)

Hepatic apolipoprotein A-I gene expression in patients with cholesterol gallstones treated with ursodeoxycholic acid
by: Nahum Méndez-Sánchez, et al.
Published: (2002-04-01)

Effect of Ursodeoxycholic Acid Alone and Ursodeoxycholic Acid Plus Domperidone on Radiolucent Gallstones and Gallbladder Contractility in Humans
by: Ilyas Tuncer, et al.
Published: (2012-01-01)

New Therapeutic Targets in Autoimmune Cholangiopathies
by: Alessio Gerussi, et al.
Published: (2020-04-01)

Cholangiopathy with Respect to Biliary Innate Immunity
by: Kenichi Harada, et al.
Published: (2012-01-01)

Cholangiopathies – Towards a molecular understanding
by: Paul K.H. Tam, et al.
Published: (2018-09-01)

Chronic Lymphocytic Leukemia-Associated Cholangiopathy
by: Jake Mann, et al.
Published: (2011-01-01)

Cholangiopathy as part of post-COVID syndrome
by: Manuel Rojas, et al.
Published: (2021-01-01)

Obliterative cholangiopathy in acquired cystic biliary atresia type III after cyst perforation: a case report
by: Tsugumichi Koshinaga, et al.
Published: (2018-05-01)

Radioimmunoassay of ursodeoxycholic acid in serum.
by: I Makino, et al.
Published: (1978-05-01)

Ursodeoxycholic acid and cancer prevention
by: A. R. Reyzis
Published: (2019-10-01)

Is ursodeoxycholic acid effective in primary biliary cirrhosis?
by: Gabriel Rada, et al.
Published: (2014-09-01)

Is ursodeoxycholic acid effective for intrahepatic cholestasis of pregnancy?
by: Sebastián Sepúlveda Marín, et al.
Published: (2016-04-01)

Diagnostic and therapeutic potentials of microRNAs in cholangiopathies
by: Lindsey Kennedy, et al.
Published: (2017-06-01)

Functional roles of gut bacteria imbalance in cholangiopathies
by: Keisaku Sato, et al.
Published: (2019-03-01)

Inflammation and the Gut-Liver Axis in the Pathophysiology of Cholangiopathies
by: Debora Maria Giordano, et al.
Published: (2018-10-01)

MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment
by: Maria Jose Lorenzo Pisarello, et al.
Published: (2015-08-01)

Toll-Like Receptors in Secondary Obstructive Cholangiopathy
by: A. G. Miranda-Díaz, et al.
Published: (2011-01-01)

Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies
by: Stefania Cannito, et al.
Published: (2018-12-01)

Weight reduction and ursodeoxycholic acid in subjects with nonalcoholic fatty liver disease. A double-blind, placebo-controlled trial
by: Nahum Méndez-Sánchez, et al.
Published: (2004-07-01)

Diet‐Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice
by: Dominique Debray, et al.
Published: (2018-12-01)

Bile acids: regulation of apoptosis by ursodeoxycholic acid
by: Joana D. Amaral, et al.
Published: (2009-09-01)

Molecular Mechanisms of Ursodeoxycholic Acid Toxicity & Side Effects: Ursodeoxycholic Acid Freezes Regeneration & Induces Hibernation Mode
by: Magd A. Kotb
Published: (2012-07-01)

Use of ursodeoxycholic acid in patients with hypertransaminasemia
by: Claudio Puoti, et al.
Published: (2014-09-01)

STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY?
by: I. N. Grigorieva, et al.
Published: (2016-01-01)

STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY?
by: I. N. Grigorieva, et al.
Published: (2016-01-01)

Effect of ursodeoxycholic acid on cholesterol absorption and metabolism in humans
by: Laura A. Woollett, et al.
Published: (2003-05-01)

Polynosological effects of ursodeoxycholic acid (UDCA). Practice of using
by: V. M. Makhov, et al.
Published: (2016-12-01)

AUTOIMMUNE PANCREATITIS AND IGG4-ASSOCIATED CHOLANGIOPATHIES (review)
by: Yu. S. Kokarev
Published: (2018-05-01)

Development of a solid-phase enzyme immunoassay for ursodeoxycholic acid: application to plasma disappearance of injected ursodeoxycholic acid in the rabbit.
by: Y Maeda, et al.
Published: (1979-11-01)

Ursodeoxycholic acid in neonatal sepsis-associated cholestasis
by: Rita Mey Rina, et al.
Published: (2014-08-01)

Ursodeoxycholic Acid and Atorvastatin in the Treatment of Nonalcoholic Steatohepatitis
by: Murat Kiyici, et al.
Published: (2003-01-01)

Enzyme-linked immunoassay of ursodeoxycholic acid in serum.
by: S Ozaki, et al.
Published: (1979-02-01)

Experience of using ursodeoxycholic acid to dissolve gallstones
by: V. V. Tsukanov, et al.
Published: (2020-01-01)